Sammyboy RSS Feed
11-03-2021, 03:20 PM
An honorable member of the Coffee Shop Has Just Posted the Following:
Less than a year before the Covid-19 pandemic ravaged the world, Novavax was facing delisting from the Nasdaq. The pharmaceutical company had poured hundreds of millions of dollars into research and development for vaccines — and yet, at 33 years old, was approaching middle age without a single approved shot.
Investors were scorning, rather than rewarding, foresight. In January 2020 short interest hit 30 per cent, according to S3 Analytics. Even after the company began work on its Covid-19...
Novavax closes in on Covid triumph after 33 years of failure (https://www.sammyboy.com/threads/novavax-closes-in-on-covid-triumph-after-33-years-of-failure.301053/)
Click here to view the whole thread at www.sammyboy.com (https://www.sammyboy.com/threads/novavax-closes-in-on-covid-triumph-after-33-years-of-failure.301053/).
Less than a year before the Covid-19 pandemic ravaged the world, Novavax was facing delisting from the Nasdaq. The pharmaceutical company had poured hundreds of millions of dollars into research and development for vaccines — and yet, at 33 years old, was approaching middle age without a single approved shot.
Investors were scorning, rather than rewarding, foresight. In January 2020 short interest hit 30 per cent, according to S3 Analytics. Even after the company began work on its Covid-19...
Novavax closes in on Covid triumph after 33 years of failure (https://www.sammyboy.com/threads/novavax-closes-in-on-covid-triumph-after-33-years-of-failure.301053/)
Click here to view the whole thread at www.sammyboy.com (https://www.sammyboy.com/threads/novavax-closes-in-on-covid-triumph-after-33-years-of-failure.301053/).